Journal Specialty Index
Infectious Disease
Topic | Issue |
Updates on Vaccination in Influenza, COVID-19 and RSV | DECEMBER 2024 ‧ VOL. 16 ‧ NO. 12 |
Update on Outpatient and Inpatient COVID-19 Treatment | DECEMBER 2024 ‧ VOL. 16 ‧ NO. 12 |
Bacterial Prostatitis – a Short Review | DECEMBER 2024 ‧ VOL. 16 ‧ NO. 12 |
An Update on HIV Testing | DECEMBER 2024 ‧ VOL. 16 ‧ NO. 12 |
Update on Respiratory Syncytial Virus Infections and Prevention Strategies | MARCH 2024 ‧ VOL. 16 ‧ NO. 3 |
Prevention of Anal Cancers: The ANCHOR Trial Results and Implications for Clinical Care | NOVEMBER 2023 ‧ VOL. 15 ‧ NO. 10 |
HPV-Associated Oropharyngeal Cancer in Hong Kong: How Distinct Is It? Could It Be the Next Epidemic Disease in Our Locality? | NOVEMBER 2023 ‧ VOL. 15 ‧ NO. 10 |
Gender-Neutral HPV Vaccination Among Adolescents in Hong Kong | NOVEMBER 2023 ‧ VOL. 15 ‧ NO. 10 |
A Snapshot of the Human Papillomavirus | NOVEMBER 2023 ‧ VOL. 15 ‧ NO. 10 |
Post Pandemic: The Current Threat of Respiratory Infections | SEPTEMBER 2023 ‧ VOL. 15 ‧ NO. 7 |
Mycoplasma genitalium Infection: An Emerging Sexually Transmitted Superbug Not to Be Ignored | DECEMBER 2022 ‧ VOL. 14 ‧ NO. 11 |
Management of Multidrug-Resistant Gram-Negative Infections: Focus on Carbapenem-Resistant Enterobacteriaceae and Carbapenem-Resistant Acinetobacter | DECEMBER 2022 ‧ VOL. 14 ‧ NO. 11 |
Latest Updates on the Prevention of Malaria | DECEMBER 2022 ‧ VOL. 14 ‧ NO. 11 |
10 FAQs About Prevention of Herpes Zoster for Healthcare Professionals | DECEMBER 2021 ‧ VOL. 13 ‧ NO. 9 |
Vaccination in Immunocompromised Adults | DECEMBER 2021 ‧ VOL. 13 ‧ NO. 9 |
Vaccination of Adolescents | DECEMBER 2021 ‧ VOL. 13 ‧ NO. 9 |
Update on Travel Vaccines | DECEMBER 2021 ‧ VOL. 13 ‧ NO. 9 |
Disseminated Mycobacterium szulgai Infection Mimicking Lung Cancer | NOVEMBER 2021 ‧ VOL. 13 ‧ NO. 8 |
Coronavirus Vaccination in Haematological Patients in Hong Kong: The Knowns and Unknowns | SEPTEMBER 2021 ‧ VOL. 13 ‧ NO. 7 |
COVID-19 Vaccines and Patients With Autoimmune Rheumatic Disease: What Do We Know So Far? | MARCH 2021 ‧ VOL. 13 ‧ NO. 3 |
Gastric Cancer Development After Helicobacter pylori Eradication | JANUARY 2021 ‧ VOL. 13 ‧ NO. 1 |
Impact of COVID-19 on Colorectal Cancer Screening: Evidence and Recommendations | JANUARY 2021 ‧ VOL. 13 ‧ NO. 1 |
Syphilis Serological Test Interpretation Made Easy | DECEMBER 2020 ‧ VOL. 12 ‧ NO. 10 |
Co-circulation of SARS-CoV-2 and Influenza Virus: The Threat of a 'Twindemic' | DECEMBER 2020 ‧ VOL. 12 ‧ NO. 10 |
Metabolic Diseases in People Living With HIV | DECEMBER 2020 ‧ VOL. 12 ‧ NO. 10 |
Updates on Antifungal Resistance and Treatment Options for Invasive Fungal Infection | DECEMBER 2020 ‧ VOL. 12 ‧ NO. 10 |
Haematological Manifestations of COVID-19 | SEPTEMBER 2020 ‧ VOL. 12 ‧ NO. 8 |
COVID-19 & Obesity - At the Intersection of a Pandemic and an Epidemic | AUGUST 2020 ‧ VOL. 12 ‧ NO. 7 |
Baloxavir, a New Weapon for an Old Enemy | MAY 2020 ‧ VOL. 12 ‧ NO. 5 |
Vaccinations in Rheumatic Disease Patients | MARCH 2020 ‧ VOL. 12 ‧ NO. 3 |
Cardiology, COVID-19 and Beyond | FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2 |
Updates on the Treatment of H. pylori Infections | JANUARY 2020 ‧ VOL. 12 ‧ NO. 1 |
Today's Science in Managing H. pylori Infection | SEPTEMBER 2018 ‧ VOL. 10 ‧ NO. 6 |
Intravenous Immunoglobulins (IVIg) in Sepsis | NOVEMBER 2017 ‧ VOL. 9 ‧ NO. 7 |
Novel Strategies for Influenza Vaccination | NOVEMBER 2017 ‧ VOL. 9 ‧ NO. 7 |
Elimination of Viral Hepatitis B and C | JULY 2017 ‧ VOL. 9 ‧ NO. 5 |
Sofosbuvir and Velpatasvir for All Genotypes of Chronic Hepatitis C Infection | JULY 2017 ‧ VOL. 9 ‧ NO. 5 |
Update on the Management of Chronic Hepatitis B Virus with Tenofovir - 2017 | MAY 2017 ‧ VOL. 9 ‧ NO. 4 |
Treatment of Bacterial Pneumonia with Ceftaroline Fosamil in the Intensive Care Unit: A Retrospective Case Series of 10 Patients | MARCH 2017 ‧ VOL. 9 ‧ NO. 2 |
Current Management of Fungal Nail Infection (Onychomycosis) | SEPTEMBER 2016 ‧ VOL. 8 ‧ NO. 6 |
Updates in the Management of Chronic Hepatitis B and Hepatitis C | SEPTEMBER 2016 ‧ VOL. 8 ‧ NO. 6 |
Neurological and Psychiatric Syndromes of HIV | MAY 2016 ‧ VOL. 8 ‧ NO. 4 |
Oral Antiretroviral Therapy to Prevent Sexual Transmission of HIV | MAY 2016 ‧ VOL. 8 ‧ NO. 4 |
Streptococcus pneumoniae Infection: Prevention is Better than Cure | MARCH 2016 ‧ VOL. 8 ‧ NO. 3 |
What are Difficult Pneumonias? How do you Diagnose and Treat Them? | NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6 |
Antibiotic Prophylaxis to Prevent Infective Endocarditis | NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6 |
The Era of the Single Tablet Regimen (STR) for HIV Disease | NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6 |
Effective Management of Post-Influenza Pneumonia with a Novel Broad-Spectrum Cephalosporin | SEPTEMBER 2015 ‧ VOL. 7 ‧ NO. 5 |
Update on Pneumococcal Infection and Prevention | JANUARY 2015 ‧ VOL. 7 ‧ NO. 1 |
Advancements in the Treatment and Prevention of HIV Infection | DECEMBER 2014 ‧ VOL. 6 ‧ NO. 8 |
Management of Chronic Hepatitis B with Entecavir - Update in 2014 | NOVEMBER 2014 ‧ VOL. 6 ‧ NO. 7 |
Facts on the MRSA Superbug | NOVEMBER 2014 ‧ VOL. 6 ‧ NO. 6 |
Current Management of HBV and HCC | NOVEMBER 2014 ‧ VOL. 6 ‧ NO. 6 |
Micafungin: Pros and Cons | JANUARY 2014 ‧ VOL. 6 ‧ NO. 1 |
Staphylococcus aureus and Atopic Dermatitis | NOVEMBER 2013 ‧ VOL. 5 ‧ NO. 6 |
Tenofovir for long-term HBV treatment: A 2013 update | SEPTEMBER 2013 ‧ VOL. 5 ‧ NO. 5 |
Management of Hepatitis C Infection: A 2013 Update | SEPTEMBER 2013 ‧ VOL. 5 ‧ NO. 5 |
Update on Chronic Hepatitis B: HBsAg Quantification and Tenofovir | SEPTEMBER 2012 ‧ VOL. 4 ‧ NO. 5 |
Management of Chronic Hepatitis B with Entecavir | JULY 2012 ‧ VOL. 4 ‧ NO. 4 |
Giving Chemotherapy or Intensive Immunosuppression to Patients Who Are Also Chronic Hepatitis B Carriers | MARCH 2011 ‧ VOL. 3 ‧ NO. 2 |
Practical Management of Community-acquired Pneumonia | DECEMBER 2010 ‧ VOL. 2 ‧ NO. 8 |
Clinical Evidence of the Quadrivalent HPV Vaccine in Adult Women over 26 | MAY 2010 ‧ VOL. 2 ‧ NO. 3 |